NCT03828123View on ClinicalTrials.gov

Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

August 18, 2017

Study Completion Date

August 18, 2017

Conditions
Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Interventions
BIOLOGICAL

Suspension of human autologous MSC 3P in 1.5 ml

Intrathecal application of Autologous Multipotent Mesenchymal Stromal Cells 3P suspension

All Listed Sponsors
collaborator

University Hospital, Motol

OTHER

lead

Bioinova, s.r.o.

INDUSTRY

NCT03828123 - Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis | Biotech Hunter | Biotech Hunter